Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ ASCRS EyeWorld Weekly: View the current issue
➤ Allogenic cell therapy receives regulatory approval for bullous keratopathy indication
➤ 24-month data on AMD photobiomodulation therapy
➤ Patient enrollment complete for Phase 3 trial evaluating topical presbyopia treatment
➤ Pre-IND meeting for treatment of corneal endothelial disease
➤ IND submitted for geographic atrophy treatment
➤ Second Phase 3 trial for dry eye disease therapy
➤ ASCRS news and events
➤ Results from investigational non-incisional glaucoma treatment
➤ Study: preservative-free latanoprost efficacy similar to preserved alternative
➤ FDA accepts priority review NDA for vitreoretinal lymphoma treatment
➤ Companies partner to develop dry eye drop
➤ Company announces lead asset in its agonist antibody pipeline
➤ ASCRS news and events
➤ FDA accepts NDA for dry eye treatment
➤ Phase 2 study moves forward for investigational ocular autoimmune therapy
➤ Fast-track designation granted for investigational retinitis pigmentosa treatment
➤ First-in-human feasibility study data from drug-eluting IOL platform
➤ Study identifies the ‘best approach’ for anti-VEGF therapy for diabetic retinopathy
➤ ASCRS news and events
Jim Ellis, MD, won The Winning Pitch Challenge at the 2021 ASCRS Annual Meeting in Las Vegas, Nevada, for the JelliSee accommodating IOL. Dr. Ellis spoke to EyeWorld about the progress made with the product since winning the competition.
➤ Bausch + Lomb acquires AcuFocus
➤ Study: novel drug delivery system sees less inflammation with preserved drops
➤ Meibomian gland atrophy common among cataract patients, study finds
➤ mRNA technology investigated for gene therapy to treat blindness
➤ Studies find new bionic vision system offers improved outcomes
➤ ASCRS news and events
The Duke University ophthalmology residents review this article from the July issue of the Journal of Cataract & Refractive Surgery.
While the concept of monovision to enhance distance vision in the dominant eye and provide functional near vision in the non-dominant eye is not new, advances in IOL technologies are providing a more coordinated visual experience compared to prior monovision options.
➤ NDA submitted for new, topical dry eye disease treatment
➤ IND submitted for persistent corneal epithelial defect treatment
➤ IND filed for dry eye disease treatment
➤ Study: Investigational topical drop reduces inflammation in anterior uveitis cases
➤ Alcon completes acquisition of Aerie
➤ ASCRS news and events
Ever since Shin Yamane, MD, PhD, introduced flanged intrascleral haptic fixation with a double-needle technique, surgeons have been refining and building upon this technique. A recent paper adds to the body of research on the flanged method of intrascleral haptic fixation, with Kronschläger et al. describing how to “[attain] optimal flange size with 5-0 and 6-0 polypropylene sutures for scleral fixation.”
➤ FDA approves AI-based diabetic retinopathy screener
➤ FDA accepts NDA for Demodex treatment
➤ Phase 2b results for MGD therapy
➤ Phase 1/2 trial evaluates investigational TED treatment
➤ Phase 1 clinical trial to study synthetic cannabinoid derivative for glaucoma
➤ OCT company rebrands
➤ ASCRS news and events
